Paul Singer’s Elliott Investment Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund exited two positions ...
I forget a lot of things as I too rapidly approach the onus of octogenariasm. Like what I had for breakfast just a few hours ago. OK, not that really, as a man of habitual rhythm, that meal has been ...
I forget a lot of things as I too rapidly approach the onus of octogenariasm. Like what I had for breakfast just a few hours ...
Palm Beach, Fla.-based Atria Health has launched a new, independence-forward partnership model for cardiology practices.
Amgen's Wezlana leading ustekinumab biosimilar launches, potentially driving savings and access, as highlighted by Dracey ...
Ansell’s focus is on its key brands across industrial and healthcare settings. Each market is quite fragmented and Ansell’s market share varies by subsegment, but the firm has consistently held the ...